Published in Lab Law Weekly, June 23rd, 2006
Through this transaction, Angiotech will acquire all of Quill's technology and intellectual property, including the Contour Threads product line, which under its current license agreement is marketed and sold by Angiotech's Surgical Specialties division for use in aesthetic and cosmetic surgery.
"This acquisition allows us to capitalize...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly